You don't seem to have a good grasp of Virax's predicament.
The issue of not whether they raise capital at a good share price (positive trial results) or low share price (poor trial results), the issue is whether they raise capital at a low share price (positive trial results) or go out of business (poor trial results).
- Forums
- ASX - By Stock
- VHL
- commercial development of vaccines
commercial development of vaccines, page-11
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online